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Heparan sulfate can bind several adhesionmolecules
involved in lymphocyte trafficking. However, the
in vivo function of endothelial heparan sulfate in
lymphocyte homing and stimulation of the immune
response has not been elucidated. Here, we gener-
ated mutant mice deficient in the enzyme Ext1, which
is required for heparan sulfate synthesis, in a Tek-
dependentand induciblemanner.Chemokinepresen-
tation was diminished in themutantmice, causing the
lack of appropriate integrin-mediated adhesion, and
resulted in a marked decrease in lymphocyte sticking
to high endothelial venules and in recruitment of
resident dendritic cells through lymphatic vessels to
the lymph nodes. As a consequence, mutant mice
displayed a severe impairment in lymphocyte
homing and a compromised contact hypersensitivity
response. By contrast, lymphocyte rolling was
increased because of loss of electrostatic repulsion
by heparan sulfate. These results demonstrate critical
roles of endothelial heparan sulfate in immune surveil-
lance and immune response generation.
INTRODUCTION
Immune surveillance requires continuous recruitment of both
lymphocytes from blood circulation and antigen presenting cells
from peripheral tissues to lymph nodes, where they can interact
in order to initiate an adaptive immune response (Butcher and
Picker, 1996; Marchesi and Gowans, 1964). Dendritic cells and
other antigen presenting cells enter lymph nodes through
afferent lymphoid vessels, whereas lymphocytes enter lymph
nodes through a specialized vasculature of high endothelial
venules (HEVs). Homing of lymphocytes to lymph nodes involvesImultiple stepwise interactions between lymphocytes and HEV
cells, including L-selectin-mediated cell rolling and tethering,
chemokine-mediated integrin activation, and integrin-mediated
cell sticking or firm adhesion, which leads to transmigration
across blood vessels (McEver and Zhu, 2010; Rosen, 2004;
Springer, 1994; von Andrian and Mempel, 2003).
Molecular and cell-based studies indicate that heparan sulfate
binds in vitro to several major molecules including L-selectin,
chemokines, and integrins involved in lymphocyte homing
(Parish, 2006). In HEV, we and others have demonstrated
that a specialized carbohydrate termed 6-sulfo sialyl Lewis X
(sialic acida2/3Galb1/4[Fuca1/3(sulfo/6)]GlcNAc, 6-sulfo
sLeX) is the functional ligands for L-selectin byanalysesofmutant
mice deficient in fucosyltransferase (FucT) IV and VII (Homeister
et al., 2001), core 2 N-acetylglucosaminyltransferase (GnT)-1
(Ellies et al., 1998; Yeh et al., 2001), N-acetylglucosamine-6-O-
sulfotransferases (GlcNAc6ST) -1 and -2 (Kawashima et al.,
2005; Uchimura et al., 2005), and core 1 b3GnT and core 2
GnT-1 (Mitoma et al., 2007). However, sulfation of heparan
sulfate in lung endothelial cellswas recently reported tomodulate
L-selectin binding and L-selectin-mediated cell rolling in lung
microcapillaries (Wang et al., 2005). Thus, the in vivo contribution
of endothelial heparan sulfate in L-selectin-mediated lymphocyte
rolling during lymphocyte homing remains obscure.
Most chemokines, including the secondary lymphoid chemo-
kine CCL21 (also called SLC), which is indispensable for lympho-
cyte homing, bind in vitro to heparan sulfate or its highly sulfated
analog heparin (Lortat-Jacob et al., 2002). Heparan sulfate-
bound chemokines are recognized by chemokine receptors
such as CCR6 and CCR7, thereby activating integrins leading
to lymphocyte extravasation (von Andrian and Mempel, 2003).
Multiple lines of evidence indicate that heparan sulfate functions
in transcytosis, presentation, and gradient formation of chemo-
kines to promote lymphocyte migration (Lander et al., 2002;
Middleton et al., 1997). Studies utilizing in vitro flow chamber
models have shown that under shear flow, the cell-bound che-
mokine (CCL21) but not soluble CCL19 activate integrins on roll-
ing lymphocytes to allow interaction with its ligand, intercellularmmunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc. 817
Immunity
Heparan Sulfate Controls Leukocyte Traffickingadhesion molecule 1 (ICAM-1) (Shamri et al., 2005). However,
the physiological role of HEV heparan sulfate in the chemo-
kine-mediated lymphocyte homing has not been determined.
Recruitment of antigen-bearing dendritic cells from peripheral
tissues to lymph nodes is crucial for adaptive immune response
generation. The migration of dendritic cells is directed by both
the cell-bound chemokine CCL21 and the soluble chemokine
CCL19, which form a gradient in the intestinal tissue to guide
the tissue resident dendritic cells to move toward draining lymph
nodes via lymphatic vessels (Baje´noff et al., 2006; Schumann
et al., 2010). It is not knownwhether heparan sulfate, in particular
lymphatic endothelial heparansulfate, playsa role in thisprocess.
To examine the pathophysiological functions of endothelial
heparan sulfate in the recruitment of lymphocytes and dendritic
cells to lymph nodes, we first inactivated the exostoses-1 (Ext1)
gene, which is required for the formation of heparan sulfate
chains, in a Tek-dependent manner, but homozygous mice
died before birth. To bypass the embryonic lethality, we
generated transgenic mice harboring a tetracycline-controlled
transactivator (rtTA) gene under Tek promotor (Tek-rtTA) and
inactivated Ext1 in a Tek-dependent and inducible manner.
With this mouse model, we demonstrate in this study that
heparan sulfate is critically required for chemokine immobiliza-
tion and functional presentation on the cell surface of both
HEV cells and lymphatic endothelial cells. Removal of endothe-
lial heparan sulfate diminishes lymphocyte sticking during
lymphocyte homing and decreases recruitment of dendritic cells
via lymphatics to lymph node, which leads to a compromised
response in contact hypersensitivity. We also found that endo-
thelial heparan sulfate antagonizes L-selectin-counterreceptor
interactions in HEV, thus attenuating lymphocyte rolling. These
results establish crucial but multifaceted functions of endothelial
heparan sulfate in lymphocyte homing and dendritic cell recruit-
ment, and thereby immune response generation.
RESULTS
Enzymatic Removal of Endothelial Heparan Sulfate
Diminishes Lymphocyte Homing
To assess the in vivo function of HEV heparan sulfate in lympho-
cyte homing, we infused a mixture of heparitinase and heparin-
ase (hereafter, ‘‘HSases’’ is used) to wild-type (WT) mice through
the tail veins to enzymatically remove the endothelial heparan
sulfate in HEV. Lymphocyte homing to both peripheral lymph
nodes (PLNs) and mesenteric lymph nodes (MLNs) of the
HSase-infused mice was significantly decreased compared
with those of PBS-infused mice (Figure 1A). Less than 20% of
homing activity to PLNs was detected in HSase-infused mice.
No decrease, but rather a slight increase, in homing was found
for those infused with chondroitinase ABC (CSase ABC) (Fig-
ure 1A), which degrades chondroitin sulfate and dermatan
sulfate in addition to hyaluronic acid. In these assays, either
HSases or CSase ABC specifically degraded their respective
glycosaminoglycans on both the luminal surface and subcellular
matrix of lymph node HEV endothelial cells (Figure 1B). By
contrast, treatment of lymphocytes with HSases had no effect
at all in the homing to lymph nodes (Figure 1C). These results
demonstrated a specific and critical role of heparan sulfate on
HEV in the homing of lymphocytes to lymph nodes.818 Immunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc.Antigen MECA-79+ lymph node HEV cells express two major
membrane heparan sulfate proteoglycans (PGs), syndecan-4
and glypican-1, and a minor proteoglycan, syndecan-2 (Fig-
ure 1D). Immunoblotting confirmed the predominant expression
of syndecan-4 and glypican-1 in lymph node HEV (Figure 1E).
However, we detected no alteration in the lymph node cellularity
and lymphocyte homing in the syndecan-4-deficient mice
(Ishiguro et al., 2000) compared to WT mice (data not shown).
These results indicate that multiple heparan sulfate PGs in lymph
node HEV cells collectively contribute to regulation of lympho-
cyte homing.
Conditional Inactivation of Ext1 in an Inducible Manner
To determine the physiological function of endothelial
heparan sulfate in immune surveillance and chronic inflamma-
tion, we initially crossbred Tek-Cre mice (Koni et al., 2001) with
Ext1flox/flox mice (Inatani et al., 2003) to delete Ext1 in endothelial
cells. No such conditional homozygous mice were born, indi-
cating an embryonic lethality of the conditionally ablated mice
(data not shown). To bypass embryonic lethality, we used a
Tet-on system-based inducible targeting approach to inactivate
Ext1 in endothelial cells and leukocytes only at adult stage by
crossbreeding of Tek-rtTA mice, Tet-Cre mice (Belteki et al.,
2005), and Ext1flox/flox mice. To generate Tek-rtTA transgenic
mice, we made a transgenic vector containing the mouse Tek
promoter (Schlaeger et al., 1997), rtTA with a poly A sequence,
and the full-length mouse Tek enhancer (Figures S1A and S1B
available online). Among nine transgenic mouse clones with
Tek-rtTA gene (Figure S1C), two independent transgenic clones
(#8 and #29) exhibited identical specificity and effectiveness in
b-galactosidase recombination in Rosa26r reporter mice (Fig-
ure S2), and the #29 mouse line was used hereafter. Whole-
mount staining for b-galactosidase by X-gal solution of the
intercrosses of Tek-rtTA, Tet-Cre and Rosaflox/flox (Tek-rtTA+:
Tet-Cre+:Rosaflox/wt) with or without 2 weeks of doxycycline
(Dox) treatment through drinking water indicated that the vascu-
lature, lymphocytes, and hematopoietic cells of the heart, lung,
aorta, and lymph nodes were positive, which is consistent with
the reported expression profile of the Tek gene (Koni et al.,
2001). By contrast, those of Tek-rtTA+:Tet-Cre-:Rosaflox/wt were
negative (Figure S2). Notably, some vasculatures in the lung
and lymphocytes in the lymph nodes of the Tek-rtTA+:Tet-Cre+:
Rosaflox/wt without Dox treatment are weak positive for X-gal,
indicating a baseline, Dox-independent expression in the
system.
To inactivate heparan sulfate synthesis, Tek-rtTA+:Tet-Cre+:
Ext1flox/wt mice were further crossbred with Ext1flox/flox mice to
generate Tek-rtTA+:Tet-Cre+:Ext1flox/flox mice (Figure S1A).
Thesemice were born and thrived normally and showed no over-
all difference from their control Tek-rtTA+:Tet-Cre:Ext1flox/flox
and Tek-rtTA:Tet-Cre:Ext1flox/flox littermates. Dox administra-
tion of 1-month-old mice brought a gradual loss of heparan
sulfate in lymph node HEV of Tek-rtTA+:Tet-Cre+:Ext1flox/flox
(mutant mice), whereas no change was detected for the similar
Dox-treated control mice (Figure S3A).
After a 3 week treatment with Dox, heparan sulfate expression
was barely detectable in the HEV of mutant mice, whereas
CD31+ vasculatures and core protein of the basement
membrane heparan sulfate PG, perlecan, were both distributed
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Figure 1. Diminished Lymphocyte Homing upon Enzymatic Removal of Endothelial Heparan Sulfate
(A) Homing of labeled WT lymphocytes to lymph nodes of enzyme-infused WT mice. Chondroitinase ABC (CSase ABC) or a mixture of heparitinase and
heparinase (HSases) in PBS was injected through mouse tail veins 2 hr before cell injection (n = 3–5). PBS was infused as a control. *p < 0.05; ***p < 0.001, versus
PBS.
(B) Immunostaining of lymph node frozen sections. Monoclonal antibodies (mAbs) 10E4 and 3G10 detected intact heparan sulfate and digested HS proteogly-
cans (DHS), respectively, whereas mAbs CS56 and 2B6 stained chondroitin sulfate and digested CS proteoglycans (DCS), respectively. Scale bar represents
50 mm.
(C) Homing of HSase-treated and labeled lymphocytes from WT mice to the lymph nodes of WT mice. PBS treatment was run as a control.
(D) RT-PCR analysis of membrane-associated heparan sulfate proteoglycans in isolated MECA-79+ cells from WT mice and a control mouse myoblast cell line
C2C12.
(E) Immune blot of lymph node vascular heparan sulfate proteoglycans. Matrix of lymph nodes from the WT mice that received Hsases and CSase ABC was
solubilized with Triton X-100-containing buffer, separated by SDS-PAGE, and blotted with mAb 3G10. Equal amounts of proteins were loaded on each lane.
The migration position of perlecan, glypican-1 (Gpn1), and syndecan-4 (Syn4) are indicated.
Data in (A) and (C) are representative of four independent experiments (mean ± SE).
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Heparan Sulfate Controls Leukocyte Traffickingnormally in the lymph nodes (Figure 2A; Figure S3A). Polymerase
chain reaction (PCR) analyses of freshly isolated MECA-79+
lymph node HEV cells from mutant mice showed minimal levels
of Ext1mRNA and robust signals for inactivated Ext1 (Figure 2B).
As expected from the X-gal staining, a low level of genomic Ext1
deletion was seen in cells of the mice that received no Dox
(Figure 2B). Immunoblotting analysis of isolated CD31+ lung
panendothelial cells showed a reduced molecular size of synde-
can-4 in mutant mice (Figure 2C). The size was not altered by
further treatment with HSases, but treatment with both HSases
and CSase ABC resulted in further reduction of syndecan-4
size to about 35 kda (Figure 2C). Enzyme-linked immunosorbentIassay (ELISA) showed that approximately 90% of heparan
sulfate on syndecan-4 in lung panendothelial cells was lost
in the mutant mice compared to control mice (Figure 2D). In
addition, consistent with the X-gal staining, a similar deletion
profile of Ext1 gene in splenic lymphocytes of mutant mice was
also detected (Figures S3B and S3C).
Overall, these results indicate that we have generated an
in vivo recombination system, which specifically and efficiently
deletes virtually all heparan sulfate in endothelial cells
including lymph node HEV in adult mice. To our knowledge,
this is the first live animal model that lose endothelial heparan
sulfate.mmunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc. 819
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Figure 2. Inducible Abrogation of Endothelial Heparan Sulfate in Ext1 Mutant Mice
(A) Immunostaining of high endothelial venule (HEV) heparan sulfate in frozen lymph node (LN) sections by mAb 10E4. Costaining with CD31 or perlecan was
performed. Scale bar represents 50 mm.
(B) Analysis of PCR products of Ext1 in HEV cells isolated from the control and mice. DExt1 denotes deficient Ext1 gene.
(C) Immune blot of syndecan-4 (Syn-4) in lung endothelial cells isolated from control andmutant mice. Pretreatment with amixture of heparitinase and heparinase
(Hsases) and/or chondroitinase ABC (CSase ABC) at 37C for 1 hr was included.
(D) ELISA of heparan sulfate chains on syndencan-4 or control (IgG) immunoprecipitate from lung endothelial cells of the control and mutant mice by using mAb
10E4. Data are expressed as mean ± SD.
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Heparan Sulfate Controls Leukocyte TraffickingDiminished Lymphocyte Homing in Ext1 Mutant Mice
because of Decreased Chemokine Presentation
After 3 weeks of Dox treatment, mutant mice showed no gross
abnormalities, but cell numbers of PLN, MLN, and PP (Peyer’s
patches) were all about 50% lower than those of control mice
(Figure 3A). By contrast, the numbers of lymphocytes and gran-
ulocytes in the peripheral blood are increased (Figure 3B), similar
to that observed in FucT-IV/:FucT-VII/ mice (Homeister
et al., 2001). Lymph node cellularity was further reduced after
a 2 month treatment with Dox and the gross sizes of PLNs
were smaller than those of control mice (Figure 3C, insert). This
difference in the cell number was not due to an altered cell
proliferation based on in vitro assessment by using mitogen
concanavalin A (Figure 3D), a finding consistent with a previous
report that T or B cell-specific deletion of heparan sulfate does
not alter T and B cell proliferation (Garner et al., 2008). Both
T cells and B cells appeared similarly affected (Figure 3E). In
line with the reduced cellularity, homing of lymphocytes to820 Immunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc.PLN, MLN, and PP was all significantly decreased (Figure 3F).
The remaining one-third of homing activity in PLNs of mutant
mice was further reduced to background amounts by a tail
vein infusion of HSases (Figure 3F, left), whereas a slightly
increased homing to spleen was detected in mutant mice (Fig-
ure 3F, right). On the other hand, lymphocytes isolated from
control and mutant mice had the same capability of homing to
wild-type lymph nodes (Figure 3G), indicating that Ext1 gene
abrogation in lymphocytes has no effect on their homing activity.
The spatial distribution of T and B cells in the lymph nodes in the
mutant mice was also normal (Figure 3H). These results together
demonstrate that endothelial heparan sulfate but not lymphocyte
heparan sulfate plays a decisive role in lymphocyte homing.
Intravital microscopic analysis showed a reduced sticking of
T lymphocytes in typical lymph node HEV order III venules
(M’Rini et al., 2003) of the mutant mice when compared to that
of control mice (Figure 4A). This situation was similar to pertussis
toxin-treated mice (Warnock et al., 1998). Under the same
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Figure 3. Impaired Lymphocyte Homing and Lymph Node Cellularity in Ext1 Mutant Mice
(A) Cell numbers of secondary lymphoid organs in mice that received doxcycline for 3–4 weeks (n = 5–9).
(B) Numbers of white blood cells (WBC) and subtypes in the peripheral blood of the mice after 4 weeks treatment with doxycyline (n = 8).
(C) Cell numbers of PLNs in the mice that received doxcycline for 2 months (n = 4–6). Insert shows the visual size of the representative inguinal lymph nodes from
both mouse lines. Scale bar represents 0.5 cm.
(D) Proliferation of lymph node cells stimulated by Concanavalin A at a dose of 2 mg/ml.
(E) Populations of T cells (CD3+) and B cells (B220+) in secondary lymphoid organs.
(F) Homing of labeled lymphocytes fromWTmice to the secondary lymphoid organs of the control and the mutant mice (n = 3–5). An infusion of heparitinase and
heparinase (HSases) was included for the mutant mice.
(G) Homing of labeled lymphocytes isolated from the control or the mutant mice to the lymph nodes of WT mice (n = 3–5).
(H) Immunostaining of lymph node sections with anti-CD3 (in red) and anti-B220 (in green). Scale bar represents 200 mm.
*p < 0.05; **p < 0.01, versus controls. Data are representative of two or three independent experiments (mean ± SE).
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Heparan Sulfate Controls Leukocyte Traffickingconditions, only a slight increase in blood flow velocity was
observed (Vblood in Table S1). The diminished lymphocyte
sticking in order III venules was associated with the decrease of
lymphocyte rolling velocity (Figure 4B, right), indicating that
lymphocytes slowly kept rolling rather than arrest on endothelium
in the absence of heparan sulfate. Loss of HEV heparan sulfateIwas accompanied by a loss of endothelial presentation of endog-
enous CCL21 and CCL2 (Figure 4C and Figure S4), but no alter-
ation in the expressions of MECA-79 antigen, L-selectin ligands,
or ICAM-1 (Figure 4C) was observed. The little remaining CCL21
in the HEV of mutant mice could bind to the residual heparan
sulfate and/or other molecules such as collagen IV (Yang et al.,mmunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc. 821
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Figure 4. Diminished Sticking and Decreased Rolling Velocity of Lymphocytes in Ext1 Mutant Mice
(A) Sticking fraction of T cells in orders II and III lymph node venules analyzed by intravital microscopy. Combined results of 6–7 venules for order II and 13 venules
for order III from 8 mice of each group are shown.
(B) Cumulative rolling velocity of T cells in orders II and III lymph node venules of control and mutant mice (n = 8). The percentage of rolling cells is expressed as
function of Vroll (see Experimental Procedures).
(C) Immunostaining of MECA-79 antigen (MECA-79), L-selectin ligands (L-sel-IgM), intercellular adhesion molecule-1 (ICAM-1), chemokines CCL21 and CCL2,
and laminin (LN) in lymph node frozen sections. Scale bars represent 50 mm.
(D) Homing of labeled lymphocytes isolated from WT or Ccr7+/– mice to the lymph nodes of WT mice or Ext1+/– mice (n = 4).
(E) Rolling fraction of T cells in orders II and III lymph node venules analyzed by intravital microscopy. Combined results of 6–7 venules for order II and 13 venules
for order III from 8 mice of each group are shown.
Mean values are shown as horizontal bars in (A) and (E). *p < 0.05, versus control mice (unpaired t test).
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Heparan Sulfate Controls Leukocyte Trafficking2007). Heparan sulfate and CCL21 in the fibroblastic reticular
networkwasnot, however, affected in themutantmice (Figure 4C
andFigureS4B), suggesting a role of heparan sulfate synthesized
by stromal cells in presenting CCL21 in the fibroblastic reticular
network. CCL21 is a critical chemokine for lymphocyte homing
(Nakano et al., 1998). CCR7 is the cognate receptor on lympho-
cytes for CCL21 (Fo¨rster et al., 1999). We found that homing of822 Immunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc.lymphocytes in Ccr7+/ mice to Ext1+/ mice lymph nodes was
significantly lower than homing of lymphocytes in WT mice to
the same Ext1+/ mouse lymph nodes or Ccr7+/ lymphocytes
in WT mice (Figure 4D), indicating that HEV heparan sulfate is
genetically connected to the CCL21-CCR7 signaling for lympho-
cyte homing. These results demonstrate that endothelial heparan
sulfate plays an essential role in immobilization and presentation
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Figure 5. Rolling of 38C13 Cells on CHO Cells Expressing 6-Sulfo sLeX or sLeX on N-Glycans and O-Glycans
(A) Rolling of 38C13 cells on CHO cells expressing 6-sulfo sLeX on bothN- andO-glycans (CHO:CD34:FucT-VII:C1:C2:GlcNAc6ST-2) or on CHO cells expressing
only N-glycans sLeX (CHO:CD34:FucT-VII) without enzyme treatment (-) or treated with chondroitinase ABC (CSase ABC), heparitinase, and heparinase
(HSases) (+).
(B) Cell rolling on CHO cells expressing 6-sulfo sLeX on both N- and O-glycans treated with individual enzyme described in (A).
(C) Rolling velocity on PBS- or HSase-treated CHO cells expressing 6-sulfo sLeX as shown in (B).
Data are representative of two independent experiments (mean ± SE).
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Heparan Sulfate Controls Leukocyte Traffickingof chemokines including CCL21 and thereby in the regulation of
lymphocyte sticking in lymph node HEV.Increased Lymphocyte Rolling in HEV of Mutant Mice
Apart from the reduced lymphocyte sticking in mutant mice, we
noticed reduced rolling velocity in MECA-79+ order III venules
(Figure 4B) along with an increased rolling of T cells in order II
venules (Figure 4E), suggesting that endothelial heparan sulfate
negatively regulates L-selectin-mediated cell rolling. Order II
venules are downstream from order III venules. It is thus possible
that lymphocytes, which begin to roll in higher-order venules (III,
IV, and V) yet fail to stick because of lack of heparan sulfate, may
simply continue rolling through downstream orders, resulting in
higher rolling fraction in order II venules without decrease in
rolling velocity (Figure 4B). Immunofluorescence staining
showed indistinguishable expression of L-selectin ligands in
HEV of control and mutant mice (Figure 4C). Analysis of splenic
T and B cells also showed a normal expression of L-selectin at
both mRNA and protein levels in mutant mice (Figures S3B
and S3C). These results indicate that genetic removal of
endothelial heparan sulfate had no effect in the expression of
L-selectin in lymphocytes and of L-selectin ligands in HEV.
To delineate the effects of cell surface heparan sulfate in
L-selectin-mediated lymphocyte rolling, we measured the rolling
of 38C13 B cells (van Zante et al., 2003) on genetically engi-
neered Chinese hamster ovary (CHO) cells, which mimic the
glycan profile of HEV cells by stably expressing O- and
N-glycan-based 6-sulfo sLeX (Mitoma et al., 2007) in a flow
chamber before and after HSase and CSase ABC digestion (Fig-
ure S5C). These CHO cells supported the rolling of lymphocytes
under shear flow, and the rolling was increased after both
heparan sulfate and chondroitin sulfate and dermatan sulfate
or only heparan sulfate were removed (Figures 5A and 5B). In
contrast, CHO cells expressing only CD34 and FucT-VII barelyIsupported lymphocyte rolling, and treatment with both HSase
and CSase ABC had no effect on cell rolling (Figures 5A and
5B). Consistently, the rolling velocity on HSase-treated 6-sulfo
sLeX-expressing cells decreased compared with PBS-treated
cells (Figure 5C). Taken together, these in vitro and in vivo rolling
data indicate that cell surface heparan sulfate does not function
as L-selectin ligands to support cell rolling, but rather attenuates
L-selectin binding to ligands, most probably because of electro-
static repulsion by sulfate groups.Contact Hypersensitivity Is Altered in Mutant Mice
The above findings suggest that lymphocyte recruitment in in-
flamed tissues may also depend on endothelial heparan sulfate.
To test this hypothesis, we evaluated a contact hypersensitivity
response, which is primarily mediated by T cells (Staite et al.,
1996). Mutant mice showed significant reductions in ear swelling
and in mononuclear cell infiltration after sensitization and chal-
lenge with the hapten DNFB (2,4-dinitrofluorobenzene; Figures
6A and 6B). The recruitment of CD3+ T cells was substantially
reduced in inflamed ears of the mutant mice (Figure 6C, left,
and Figure S6A). Analysis of draining lymph nodes after sensiti-
zation indicated that both total cell number and homing activity
in the draining lymph nodes of mutant mice were lower than
those of control mice (Figure 6D). Notably, the epidermal infiltra-
tion of neutrophils (Staite et al., 1996) was evident in inflamed
control mouse ears, whereas such infiltration was significantly
reduced in the mutant mice similar to P-selectin-deficient mice
(Figure 6C, right, and Figure S6B; Subramaniam et al., 1995).
Consistent with decreased neutrophil infiltration, immobilization
of CXCL-2, which regulates neutrophil recruitment in inflamed
tissues, was diminished in the mutant mice (Figure 6E), while
lymphocytes from both mouse lines proliferated at the same
rate in response to 2,4-dinitrobenzene sulfonic acid (Figure 6F).
These results suggest that significantly decreased recruitmentmmunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc. 823
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Figure 6. Impaired Contact Hypersensitivity in Ext1 Mutant Mice
(A) Ear swelling 24 hr after challenge with DNFB or vehicle alone in control and mutant mice (n = 4–6).
(B) Hematoxylin and eosin staining of ear sections challenged with DNFB. Arrowheads are infiltrated mononuclear cells; arrows are infiltrated neutrophils; dashed
areas are epidermal areas with neutrophil clustering. Scale bar represents 250 mm.
(C) Quantitation of infiltrated T cells in inflamed ears (left) and areas of neutrophil clusters (right) (n = 3–5). Numbers of CD33+ cells in the area of 300 mm long ear
were counted, and the epidermis area with clustered neutrophils of the whole ear were measured.
(D) Cell number of sensitized draining inguinal lymph nodes (left) and lymphocyte homing to the draining inguinal lymph nodes (right) (n = 3–5).
(E) CXCL2 expression in CD31+ cells of DNFB-inflamed abdominal skins. Arrowheads indicate microvessels. Scale bar represents 25 mm.
(F) Cell proliferation isolated from sensitized inguinal lymph nodes in response to DNBS (200 mg/ml) (n = 3).
*p < 0.05; **p < 0.01, versus control mice. Data are representative of two independent experiments (mean ± SE).
Immunity
Heparan Sulfate Controls Leukocyte Traffickingof antigen-specific lymphocytes to the draining lymph nodes and
reduced neutrophil recruitment to the inflamed ear collectively
contributed to a reduced contact hypersensitivity response in824 Immunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc.mutant mice. By contrast, GlcNAc6ST-1 and -2 double-deficient
mice exhibited reduced recruitment of mononuclear cells but not
of neutrophils (Figure S6C; Kawashima et al., 2005).
C
D
11
c 
 a
nd
 C
M
FD
A
  c
el
ls
   
   
   
   
  (
x 
10
  )
0
0.4
0.8
1.2
1.6
0
4
8
12
16
Control Mutant
 C
D
11
c 
 a
nd
 F
IT
C
  c
el
ls
   
   
   
   
  (
x 
10
  )
Control Mutant
Control Mutant
 C
C
L2
1 
bi
nd
in
g
(A
BS
 a
t 4
90
 n
m
)
Control Mutant
   
H
S
 e
xp
re
ss
io
n
 (A
B
S
 a
t 4
90
 n
m
)
Control Mutant
A B C
E FD
Control Mutant
 L
ym
ph
 n
od
e 
ce
lls
 (x
 1
0 
 )6
4
C
on
tro
l
M
ut
an
t
4
+
+
+
0
2
4
6
0
0.3
0.6
0.9
1.2
1.5
0
0.5
1.0
1.5
2.0
0
1.0
2.0
3.0 CCL21
CCL21+Heparin
HSases+CCL21
CCL19
CCL19+Heparin
HSases+CCL19
mIgM
10E4
+
 C
C
L1
9 
bi
nd
in
g
(A
B
S
 a
t 4
90
 n
m
)
C
on
tro
l
M
ut
an
t
Vehicle Vehicle + DNFB
Vehicle Vehicle+DNFB
Control
 Mutant
60
0
20
40
C
D
11
c 
 c
el
ls
 p
er
 fi
el
d
+
Figure 7. Impaired Migration of Dendritic Cells to Lymph Nodes in Ext1 Mutant Mice
(A) Cell numbers of draining lymph nodes (right) and homing of dendritic cells to draining lymph nodes (left) in skin painting experiment (n = 4–5).
(B) Immunofluorescent staining of resident dendritic cells (red) in DNFB-inflamed skin epidermis. Nuclei (blue) were stained by Hoechst. Scale bar represents
100 mm.
(C) Immunofluorescence of draining lymph nodes in skin painting experiments. Arrowheads point to infiltrated FITC-bearing dendritic cells. Scale bar represents
200 mm.
(D) Homing of intrademally loaded dendritic cells to draining lymph nodes (n = 3–5).
(E) ELISA of heparan sulfate expression assessed by mAb 10E4 in cultured mouse skin lymphatic endothelial cells.
(F) Binding of recombinant mouse CCL21 or CCL19 to cultured skin lymphatic endothelial cells. In some cases, addition of heparin (100 mg/ml) or a pretreatement
with heparitinase and heparinase (HSases) at 37C for 1 hr was included.
*p < 0.05; **p < 0.01; ***p < 0.001 versus control mice. Data are expressed as mean ± SE for (A), (B), and (D), and mean ± SD for (E) and (F).
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Heparan Sulfate Controls Leukocyte TraffickingDendritic Cell Homing during Inflammation Is Impaired
in Mutant Mice
To further study the mechanism of reduced contact hypersensi-
tivity inmutant mice as shown above, we examined themigration
of tissue-resident dendritic cells to the draining lymph node, an
earlier step initiating the adaptive immune response. By using
a skin painting model, we found that the recruitment of
CD11c+ and FITC+ double-positive cells to the draining lymph
nodes was significantly lower (one third reduction) in the mutant
mice than in the control mice (Figure 7A, left). Accordingly, the
total cell number of draining lymph nodes was fewer in the
mutant mice (Figure 7A, right). Endogenous dendritic cells in
the inflamed skin of the mutant mice were not reduced as
much as those in the wild-type mice (Figure 7B), indicating that
recruitment of dendritic cells to the draining lymph nodes was
impaired. However, the recruited FITC+ cells appear to equally
enter into the T cell zone of the draining lymph nodes of both
mouse lines (Figure 7C), indicating that intranodal migration of
recruited dendritic cells was normal in the mutant mice. We
also assayed homing of exogenous bone marrow-derived
dendritic cells to the draining lymph nodes under inflammatory
condition stimulated by DNFB and detected an almost identicalIreduction of dendritic cell homing to the draining lymph nodes as
seen after FITC-skin painting (Figure 7D). These results indicate
that homing of not only lymphocytes via blood but also dendritic
cells via lymphatics was impaired in the mutant mice.
Tek gene is known to be expressed in the lymphatic endothe-
lial cells (Shimoda, 2009). In order to measure heparan sulfate of
the lymphatic endothelial cells, we cultured dermal cells in vitro
and isolated the podoplanin+ lymphatic endothelial cells (Krie-
huber et al., 2001) from the skin of control andmutant mice. Cells
from both mouse lines grew similarly in vitro. Flow cytometric
analysis showed a substantially lower expression of heparan
sulfate assessed by antibody 10E4 in the lymphatic endothelial
cells from the mutant mice compared with those of the control
mice (Figure S7A). Cell-based ELISA demonstrated more than
an 80% reduction in heparan sulfate in lymphatic endothelial
cells from the mutant mice (Figure 7E). Consequently, the
binding capacity of the mutant cells toward the exogenous
chemokines CCL21 and CCL19 was much lower than those of
control mice (Figure 7F). Immunofluorescence analysis con-
firmed the diminished presentation of CCL21 in lymphatic
vessels with a normal structural distribution in the DNFB-stimu-
lated mutant mouse skin (Figures S7B and S7C).mmunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc. 825
Immunity
Heparan Sulfate Controls Leukocyte TraffickingThese results collectively indicate that decreased expression
of heparan sulfate in lymphatic endothelial cells reduces homing
of tissue-resident dendritic cells to draining lymph nodes in
inflammatory conditions because of insufficient immobilization
of chemokines required for dendritic cell recruitment to
lymphatic vessels.
DISCUSSION
Recruitment of lymphocytes from blood circulation and dendritic
cells from peripheral tissues to the lymph nodes is essential to
maintain immune surveillance and generation of the adaptive
immune response during inflammation. Here we have provided
the in vivo evidence for the critical functions of endothelial
heparan sulfate in the homing of both lymphocytes and dendritic
cells to the lymph nodes under pathophysiological conditions by
analyzing an inducible and conditional genetically targeted
mouse model.
Lymphocyte homing is tightly controlled by three overlapping
stepwise interactions between lymphocytes and HEV cells
(Butcher and Picker, 1996; Springer, 1994). The initial rolling
step is mediated by L-selectin on lymphocytes (Arbone´s et al.,
1994), which binds to 6-sulfo sLeX and sLeX on HEV cells
(Rosen, 2004). Although heparan sulfate was shown to support
L-selectin-mediated rolling of neutrophils in lung microcapilla-
ries in acute inflammation (Wang et al., 2005), our current
studies on genetic removal of HEV heparan sulfate did not
decrease but increased the lymphocyte rolling in vivo and
in vitro, demonstrating that endothelial heparan sulfate is not
a L-selectin ligand in HEV. This conclusion is in line with the
previous reports that sLeX or its 6-sulfated analogs are entirely
responsible for the L-selectin-mediated lymphocyte homing
(Homeister et al., 2001; Kawashima et al., 2005; Mitoma et al.,
2007; Uchimura et al., 2005; Yeh et al., 2001). The distinct func-
tions of endothelial heparan sulfate in the L-selectin-mediated
leukocyte trafficking may be due to the availability of the potent
L-selectin ligand 6-sulfo sLeX and sLeX in different recruitment
sites.
Decreased cell rolling velocity after removal of heparan sulfate
is a surprise considering normal expressions of L-selectin
ligands in HEV and of L-selectin in lymphocytes in the mutant
mice. Most L-selectin counterreceptors in HEV are mucin
glycoproteins containing various numbers of O- and N-glycans
(Rosen, 2004), which have a rod-like shape and extend outward
from the cell membrane (Coltart et al., 2002; Cyster et al., 1991).
An extended form of L-selectin was also shown to enhance the
adhesion under shear flow (Phan et al., 2006). In the same
context, integrins on lymphocytes change from a bent confor-
mation to an extended conformation after chemokine stimula-
tion, thereby binding the adhesion molecule ICAM-1 on HEV
cells (Shamri et al., 2005; Shimaoka et al., 2003). Thus, the
adhesion molecules apparently favor the extended form when
they interact with counterreceptors on opposing cells (McEver
and Zhu, 2010). Heparan sulfate PGs and chondroitin sulfate
PGs are also extended molecules from the cell membrane with
high negative charge density (Bishop et al., 2007) and may
interfere with the interaction of L-selectin with 6-sulfo sLeXin
HEV via steric hindrance. It will be of interest to examine whether
glycosaminoglycans play a similar inhibitory role in regulating826 Immunity 33, 817–829, November 24, 2010 ª2010 Elsevier Inc.P-selectin- and PSGL-1-mediated cell rolling in peripheral blood
vessels.
The firm adhesion of lymphocytes in lymph node HEV requires
chemokine-mediated integrin activation. Our study demon-
strates the biological importance of HEV heparan sulfate in
chemokine immobilization and functional presentation in vivo.
The diminished lymphocyte sticking in HEV and reduced
lymphocyte homing in mutant mice or HSase-infused mice
provides direct evidence for this conclusion and is consistent
with a previous report that heparan sulfate regulates the binding
of cytokines CXCL1 and CXCL2 to lung microcapillary endothe-
lial cells in vitro (Wang et al., 2005). Thus, HEV heparan sulfate
possesses two opposite functions during lymphocyte homing:
(1) negative regulation of L-selectin-mediated cell rolling and
(2) positive regulation of chemokine-mediated cell sticking,
although the latter is the major one.
Our current studies demonstrate that heparan sulfate critically
regulates the immobilization of chemokines on lymphatic endo-
thelium and that the binding capacity of lymphatic endothelial
cells for CCL19 is about half of that for CCL21. The lower
binding capacity for CCL19 is consistent with a report showing
a weak binding of CCL19 to heparan sulfate (de Paz et al., 2007):
the heparinase treatment of lymphatic endothelium did not
remove all the binding capacity of CCL19. As such, CCL19
might bind to other cell surface molecules in addition to heparan
sulfate. CCL21 and CCL19 cause random movement and
chemotactic movement, respectively, and collaboration of
both chemokines is necessary for dendritic cell migration to
the lymph node (Schumann et al., 2010). Future studies will be
significant to determine whether the gradient of CCL19 is due
to the gradient of heparan sulfate expression in the tissue and
lymph node.
Our heparan sulfate mutant mice showed a phenotype of
reduced homing of lymphocytes and dendritic cells, which is
most reminiscent of the phenotype of Ccr7/ mice (Fo¨rster
et al., 1999) and CCL21 and CCL19 double-deficient plt/plt
mice (Nakano et al., 1998). Our mice also displayed reduced
infiltration of both mononuclear cells and neutrophils in the
contact hypersensitivity assay. The reduced neutrophil infiltra-
tion in inflamed ears in the mutant mice was most probably
due to an impaired presentation of relevant chemokines such
as CXCL2 and impaired endothelial CXCL2 gradient formation
required for the directed extravasation of neutrophils seen in
a heparanase-expressing transgenic mice (Massena et al.,
2010). On the other hand, we observed decreased recruitment
of lymphocytes but not neutrophils in GlcNAc6ST-1 and -2
double-deficient mice, whereas lymphocyte recruitment to the
lymph nodes was only marginally affected in P- and E-selectin
double-deficient mice (Staite et al., 1996). The phenotypes of
our mutant mice in pathophysiological conditions indicate that
endothelial heparan sulfate participates in the recruitment of
different types of leukocytes both from the blood circulation
into lymph nodes and from inflammatory sites into draining
lymph nodes.
Our studies showed that genetic deletion of a major heparan
sulfate PG of HEV, syndecan-4, has essentially no effect in
lymphocyte homing. This finding is consistent with the reports
showing that genetic deletion of one of L-selectin counterrecep-
tors such as GlyCAM-1 had a minimal effect on lymphocyte
Immunity
Heparan Sulfate Controls Leukocyte Traffickinghoming (Kansas, 1996). By contrast, genetic abrogation of
6-sulfo sialyl Lewis X had profound effect on lymphocyte homing
(Homeister et al., 2001; Kawashima et al., 2005; Mitoma et al.,
2007; Uchimura et al., 2005). Taken together with the present
study, these observations illustrate that the functionality of
L-selectin counterreceptors and heparan sulfate PGs are largely
dependent on their specific functional glycans.
In summary, our results have demonstrated critical functions
of endothelial heparan sulfate in the recruitment of lymphocyte
and dendritic cells to lymph nodes under both physiological
and inflammatory conditions. We thus propose endothelial
heparan sulfate as a drug target for attenuating chronic inflam-
mation. The unique animal model reported here will be useful
for studying the roles of heparan sulfates in inflammatory
diseases such as asthma and inflammatory bowl diseases and
tumor angiogenesis.
EXPERIMENTAL PROCEDURES
Mice
All mice used in the study were on a C57Bl/6 background. Syndecan-4-defi-
cient mice were obtained from T. Kojima, Nagoya University, Japan (Ishiguro
et al., 2000). Ccr7/ mice (Fo¨rster et al., 1999) and Rosa reporter mice were
from Jackson Laboratory. Ext1flox/flox line was generated as reported (Inatani
et al., 2003). Tet-Cre line was provided by A. Nagy (Belteki et al., 2005). The
generation Tek-rtTA transgenic mice and their husbandry with Tet-Cre and
Ext1flox/flox mice are described in Supplemental Experimental Procedures.
Mice were treated according to guidelines of the National Institutes of Health,
and experiments were approved by the Animal Research Committee of the
Sanford-Burnham Medical Research Institute.
Dendritic Cell Homing
In vitro culture of bone marrow-derived dendritic cells and their homing to
inflamed draining lymph nodes was performed as described (Inaba et al.,
1992; Sangaletti et al., 2005). In brief, bone marrow cells were obtained from
the thigh bones of WT mice and cultured with RPMI medium containing 5%
FBS, 5 ng/ml ofmouseGM-CSF, and 10 ng/ml ofmouse IL-4 at 37C in a humid
incubator. On day 3 and day 5, half of the culture medium was replaced with
the same volume of fresh medium containing cytokines as described above.
On day 7, loosely attached cells were harvested by pipeting and incubated
with CD11c antibody. CD11c+ cells were isolated by magnet-assisted cell
sorting (MACS) beads conjugated with anti-rat IgG and a MACS LS column
(Miltenyi Biotec GmbH). Isolated cells were labeled with 5-chloromethylfluor-
escein (CMFDA) and injected intradermally into shaved mouse abdomen
skin (53 105 cells per mouse). After 30min, 25 ml of 0.5% of DNFBwas applied
to the shaved mouse abdomen skin. Twenty-four hours later, the draining
inguinal lymph nodes were dissected and dissociated into single-cell suspen-
sion. Cells were subjected to cell number analysis via a cytometer and stained
with PE-conjugated CD11c antibody on ice, followed by flow cytometric anal-
ysis of the fractional content of CD11c+ and CMFDA+ double-positive cells.
Homing of exogenous dendritic cells were calculated by multiplying total cell
number of draining lymph nodes with fractional content of double-positive
cells as described above.
Intravital Microscopy and Image Analysis
Intravital microscopy of inguinal LNs was performed as previously described
(Warnock et al., 1998; M’Rini et al., 2003). In brief, control or mutant mice
were anesthetized and the right inguinal LN was exposed and positioned for
epifluorescence intravital microscopy. Preparations were transferred to an
intravital microscope (IV-500; Mikron Instruments, San Diego, CA), equipped
with a Rapp OptoElectronic SP-20 xenon flash lamp system (Hamburg,
Germany) and QImaging Rolera-MGi EMCCD camera (Surrey, BC). T cells
were isolated from the spleens and LNs from naiveWTmice via pan T cell isola-
tion kits (Miltenyi Biotec). T cells were fluorescently labeled with 1 ng/mL cal-
cein-AM for 20 min at 37C, and small boluses (10–50 ml of 103 106 cells/mL)Iof cells were injected via a left femoral artery catheter. Cell behavior in
LN venules was recorded in 10 min recordings through 103 or 203 water-
immersion objectives (Achroplan; Carl Zeiss). Rolling and sticking fractions
in individual vessel segments were determined offline by playback of digital
video files. Rolling fraction was determined as the percentage of cells interact-
ing with LN venules in the total number of cells passing through a vessel
during the observation period. Sticking fraction was defined as the percentage
of rolling cells that adhered in LN venules for 30 or more seconds. Vroll
was defined as the mean velocity (mm/s) of rolling cells and Vfast as the mean
velocity of noninteracting cells in each vessels. The highest velocity, Vmax,
was used to calculate the mean blood flow velocity, Vblood, via the relation:
Vblood = Vmax/(1.6- E^2) where E is the ratio of the leukocyte diameter
(as assumed to be 7 mm) to vessel diameter, as previously published
(Ley and Gaehtgens, 1991). The wall shear rate (WSR) was assessed as
WSR=Vblood*8/Dv where Dv is the vessel diameter. A cumulative velocity curve
was compiled by plotting the percentage of rolling cells at or below a given
velocity as a function of Vroll. Rolling fraction and velocities were determined
in identical venules for each condition. Statistic difference was evaluated by
unpaired t test.SUPPLEMENTAL INFORMATION
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